Evidence map›Paper›PMID 42142021›Full record

ArticleACS chemical biology2026

Design, Synthesis, and Evaluation of a Novel Phenanthrene Derivative as a Potential DNA Intercalator.

Ghada Bouz, Giulia Quaglia, Loredana Latterini, Pavel Barta, Ondřej Jand'ourek, Klára Konečná, Jan Ősterreicher, Lieve Naesens, Leentje Persoons, Jan Storch and 1 more

Abstract read
In one paragraph

Article in ACS chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ghada BouzResearch Group of Advanced Materials and Organic Synthesis, Institute of Chemical Process Fundamentals of the Czech Academy of Sciences, Rozvojova 1/135, Prague 6165 00, Czech Republic.ORCID 0000-0003-2024-5788
Giulia QuagliaNano4Light Lab, Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, Perugia06123, Italy.
Loredana LatteriniNano4Light Lab, Department of Chemistry, Biology and Biotechnology, University of Perugia, via Elce di Sotto 8, Perugia06123, Italy.ORCID 0000-0002-1021-9423
Pavel BartaFaculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové500 03, Czech Republic.
Ondřej Jand'ourekFaculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové500 03, Czech Republic.ORCID 0000-0003-4633-2062
Klára KonečnáFaculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové500 03, Czech Republic.
Jan ŐsterreicherFaculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové500 03, Czech Republic.
Lieve NaesensKU Leuven , Department of Microbiology, Immunology and Transplantation, Rega Institute, LeuvenBE-3000, Belgium.ORCID 0000-0001-9742-9302
Leentje PersoonsKU Leuven , Department of Microbiology, Immunology and Transplantation, Rega Institute, LeuvenBE-3000, Belgium.
Jan StorchResearch Group of Advanced Materials and Organic Synthesis, Institute of Chemical Process Fundamentals of the Czech Academy of Sciences, Rozvojova 1/135, Prague 6165 00, Czech Republic.
Illia PanovResearch Group of Advanced Materials and Organic Synthesis, Institute of Chemical Process Fundamentals of the Czech Academy of Sciences, Rozvojova 1/135, Prague 6165 00, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel DNA intercalators are crucial for developing new pharmacologically active agents, such as chemotherapeutics, and advanced probes for cell labeling and imaging. Herein, we report the design and two-step synthesis of a novel phenanthrene-based derivative bearing cytosine moieties (PHE-CYT-3,6-TFA), formulated as a trifluoroacetic acid salt to enhance water solubility.

Indexed as

DNADrug DesignIntercalating AgentsPhenanthrenesAntineoplastic AgentsHumansMolecular Docking SimulationAntineoplastic AgentsDNAIntercalating AgentsphenanthrenePhenanthrenes

Identifiers

PMID42142021
PMCPMC13288466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.